Cover Image


Global Artificial Organs Market - Segmented by Organ Type and Geography - Growth, Trends and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 390780
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
Back to Top
全球人造器官市場:成長,趨勢,預測 Global Artificial Organs Market - Segmented by Organ Type and Geography - Growth, Trends and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 111 Pages


第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義
  • 推動市場的要素
  • 阻礙市場的要素

第4章 市場區隔:人造器官

  • 人工心臟
  • 人工腎臟
  • 人工肝臟
  • 人工胰臟
  • 人工肺

第5章 市場區隔:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 競爭環境

  • 合併·收購
  • 新產品上市
  • 協定,聯合,聯盟
  • 市場連鎖分析
  • 價格佔有率分析

第7章 企業簡介

第8章 附錄


Product Code: 16395

The global artificial organs market report covers artificial organs that are manmade applications integrated into the human body, to replace natural organs. Artificial organs replicate the functioning of natural organs and enable patients to return to a normal life, as soon as possible. The global artificial organ market is expected to register a CAGR of 9% during the forecast period of 2018-2023.

Scarcity of Donor Organs

The lack of availability of potential organs to transplant has been a major issue of concern. There is an ever-increasing demand for organ donors, and this demand is very high when compared to the actual supply. It has been estimated that, owing to the scarcity of donor organs, among all the patients who need organ transplantation, only 10% are able to undergo the process. In the United States, more than 119,000 patients are on the waiting list for organ transplantation. Around 22 patients die each year, due to the lack of available organs for transplantation. In Europe, by the end of 2015, more than 143,000 patients were waiting for an organ transplantation. In this region, 18 patients die each year, due to lack of available organs for transplantation.

The increased incidence of disabilities and organ failures, technological advancements in the artificial organs sector, and rapidly aging population are some other drivers of the market.

Expensive Procedures

Cost of the procedure is a major constraint for the artificial organ market. The high cost of these organs can be attributed to the production policies required to address the patients, taxpayers, and medical technology corporations. For instance, organ transplantation has several issues in the current market scenario, such as the policies for procurement, transplant tourism, organ trafficking, and others.

Additionally, fear of device malfunction and its consequences are also restraining the market's growth.

North America to Dominate the Market

The global artificial organ market has been segmented by organ type and geography. By organ type, the market has been segmented into artificial heart, artificial kidney, artificial livers, artificial pancreas, and artificial lungs. By geography, it has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.

Due to increased incidences of organ failures, disabilities, and scarcity in the availability of donor organs, recent technological advancements, and the rapid rise of the geriatric population, North America dominates the market.


Reasons to Purchase this Report

Analysis of the global artificial organ market, with region-specific assessments and competition analysis on global and regional scales

Analyzing various perspectives of the industry with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3 months analyst support along with the Market Estimate sheet (in excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Market Overview
  • 5.3 Porter's Five Force Analysis
    • 5.3.1 Bargaining Power of Suppliers
    • 5.3.2 Bargaining Power of Buyers
    • 5.3.3 Degree of Competition
    • 5.3.4 Threat of Substitution
    • 5.3.5 Threat of New Entrants

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Scarcity of Donor Organs
    • 6.1.2 Increased Incidence of Disabilities and Organ Failures
    • 6.1.3 Technological Advancements in the Artificial Organ Sector
    • 6.1.4 Rapidly Aging Population
  • 6.2 Market Restraints
    • 6.2.1 Expensive Procedures
    • 6.2.2 Fear of Device Malfunction and its Consequences
  • 6.3 Opportunities
    • 6.3.1 Emerging Application in Clinical Diagnostics and Proteomics
  • 6.4 Challenges

7. Market Segmentation

  • 7.1 By Organ Type
    • 7.1.1 Artificial Heart
      • Prosthetic Heart Valves
      • Ventricular Assist Devices
    • 7.1.2 Artificial Kidney
      • Dialysis
    • 7.1.3 Artificial Livers
      • Liver Dialysis
      • Bio artificial Liver Device (BAL)
      • Molecular Adsorbent Recirculation Systems (MARS)
      • Single Pass Albumin Dialysis (SPAD)
      • Prometheus
    • 7.1.4 Artificial Pancreas
      • Insulin Pump
    • 7.1.5 Artificial Lungs
      • Extracorporeal Membrane Oxygenation
      • Heart-Lung Machines
  • 7.2 By Geography
    • 7.2.1 North America
      • US
      • Canada
      • Mexico
    • 7.2.2 Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • 7.2.3 Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
      • Rest of Asia Pacific
    • 7.2.4 The Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • 7.2.5 South America
      • Brazil
      • Argentina
      • Rest of South America

8. Competitive Landscape

  • 8.1 Mergers & Acquisitions
  • 8.2 Agreements, Collaborations & Partnerships
  • 8.3 New Product Launches

9. Key Players

  • 9.1 Edward Life sciences Corporation
  • 9.2 Asahi Kasei Medical Co. Ltd
  • 9.3 Jarvik Heart Inc.
  • 9.4 Boston Scientific Corporation
  • 9.5 Cochlear Limited
  • 9.6 Touch Bionics
  • 9.7 Ossur
  • 9.8 Medtronic Inc.
  • 9.9 Lifenet Health

10. Future of the Market

Back to Top